1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021 May;71(3):209–49.
2. Bruni L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J et al. Human Papillomavirus and Related Diseases in the World- Summary report. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre) [Internet]. 2019;(June):307. Available from: https://hpvcentre.net/statistics/reports/XWX.pdf
3. Abudu EK, Akinbami OS. Cancers in young patients in Uyo (Niger-delta region of Nigeria): magnitude of the problem and histopathological prolife. Rare Tumors. 2016;8(1):6–9.
4. Islam RM, Billah B, Hossain MN, Oldroyd J. Barriers to cervical cancer and breast cancer screening uptake in low-income and middle-income countries: a systematic review. Asian Pac J Cancer Prev. 2017;18(7):1751–63.
5. Bogani G, Lalli L, Sopracordevole F, Ciavattini A, Ghelardi A, Simoncini T, et al. Development of a Nomogram Predicting the risk of Persistence/Recurrence of cervical dysplasia. Vaccines (Basel). 2022;10(4):1–11.